Global Preclinical Magnetic Particle Imaging (MPI) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 62

Published Date: 09 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

MPI is a tomographic imaging technique that detects the magnetic properties of iron-oxide nanoparticles injected into the bloodstream to produce threedimensional images. 
According to our (Global Info Research) latest study, the global Preclinical Magnetic Particle Imaging (MPI) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Preclinical Magnetic Particle Imaging (MPI) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Preclinical Magnetic Particle Imaging (MPI) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Preclinical Magnetic Particle Imaging (MPI) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Preclinical Magnetic Particle Imaging (MPI) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Preclinical Magnetic Particle Imaging (MPI) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Preclinical Magnetic Particle Imaging (MPI)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Preclinical Magnetic Particle Imaging (MPI) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medicilon, Bruker Corporation, Mediso and Magnetic Insight, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Preclinical Magnetic Particle Imaging (MPI) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Structural Imaging
    Functional Imaging

Market segment by Application
    Pharmaceutical Companies
    Contract Research Organization (CRO’s)
    Biotech Companies
    Others

Market segment by players, this report covers
    Medicilon
    Bruker Corporation
    Mediso
    Magnetic Insight

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Preclinical Magnetic Particle Imaging (MPI) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Preclinical Magnetic Particle Imaging (MPI), with revenue, gross margin and global market share of Preclinical Magnetic Particle Imaging (MPI) from 2018 to 2023.
Chapter 3, the Preclinical Magnetic Particle Imaging (MPI) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Preclinical Magnetic Particle Imaging (MPI) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Preclinical Magnetic Particle Imaging (MPI).
Chapter 13, to describe Preclinical Magnetic Particle Imaging (MPI) research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Preclinical Magnetic Particle Imaging (MPI)
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Preclinical Magnetic Particle Imaging (MPI) by Type
        1.3.1 Overview: Global Preclinical Magnetic Particle Imaging (MPI) Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type in 2022
        1.3.3 Structural Imaging
        1.3.4 Functional Imaging
    1.4 Global Preclinical Magnetic Particle Imaging (MPI) Market by Application
        1.4.1 Overview: Global Preclinical Magnetic Particle Imaging (MPI) Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical Companies
        1.4.3 Contract Research Organization (CRO’s)
        1.4.4 Biotech Companies
        1.4.5 Others
    1.5 Global Preclinical Magnetic Particle Imaging (MPI) Market Size & Forecast
    1.6 Global Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast by Region
        1.6.1 Global Preclinical Magnetic Particle Imaging (MPI) Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Preclinical Magnetic Particle Imaging (MPI) Market Size by Region, (2018-2029)
        1.6.3 North America Preclinical Magnetic Particle Imaging (MPI) Market Size and Prospect (2018-2029)
        1.6.4 Europe Preclinical Magnetic Particle Imaging (MPI) Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Market Size and Prospect (2018-2029)
        1.6.6 South America Preclinical Magnetic Particle Imaging (MPI) Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Preclinical Magnetic Particle Imaging (MPI) Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Medicilon
        2.1.1 Medicilon Details
        2.1.2 Medicilon Major Business
        2.1.3 Medicilon Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
        2.1.4 Medicilon Preclinical Magnetic Particle Imaging (MPI) Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Medicilon Recent Developments and Future Plans
    2.2 Bruker Corporation
        2.2.1 Bruker Corporation Details
        2.2.2 Bruker Corporation Major Business
        2.2.3 Bruker Corporation Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
        2.2.4 Bruker Corporation Preclinical Magnetic Particle Imaging (MPI) Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bruker Corporation Recent Developments and Future Plans
    2.3 Mediso
        2.3.1 Mediso Details
        2.3.2 Mediso Major Business
        2.3.3 Mediso Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
        2.3.4 Mediso Preclinical Magnetic Particle Imaging (MPI) Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Mediso Recent Developments and Future Plans
    2.4 Magnetic Insight
        2.4.1 Magnetic Insight Details
        2.4.2 Magnetic Insight Major Business
        2.4.3 Magnetic Insight Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
        2.4.4 Magnetic Insight Preclinical Magnetic Particle Imaging (MPI) Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Magnetic Insight Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Preclinical Magnetic Particle Imaging (MPI) Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Preclinical Magnetic Particle Imaging (MPI) by Company Revenue
        3.2.2 Top 3 Preclinical Magnetic Particle Imaging (MPI) Players Market Share in 2022
        3.2.3 Top 6 Preclinical Magnetic Particle Imaging (MPI) Players Market Share in 2022
    3.3 Preclinical Magnetic Particle Imaging (MPI) Market: Overall Company Footprint Analysis
        3.3.1 Preclinical Magnetic Particle Imaging (MPI) Market: Region Footprint
        3.3.2 Preclinical Magnetic Particle Imaging (MPI) Market: Company Product Type Footprint
        3.3.3 Preclinical Magnetic Particle Imaging (MPI) Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Preclinical Magnetic Particle Imaging (MPI) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application (2018-2023)
    5.2 Global Preclinical Magnetic Particle Imaging (MPI) Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2029)
    6.2 North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2029)
    6.3 North America Preclinical Magnetic Particle Imaging (MPI) Market Size by Country
        6.3.1 North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2029)
        6.3.2 United States Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        6.3.3 Canada Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        6.3.4 Mexico Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2029)
    7.2 Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2029)
    7.3 Europe Preclinical Magnetic Particle Imaging (MPI) Market Size by Country
        7.3.1 Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2029)
        7.3.2 Germany Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        7.3.3 France Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        7.3.5 Russia Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        7.3.6 Italy Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Market Size by Region
        8.3.1 Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Region (2018-2029)
        8.3.2 China Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        8.3.3 Japan Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        8.3.4 South Korea Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        8.3.5 India Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        8.3.7 Australia Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2029)
    9.2 South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2029)
    9.3 South America Preclinical Magnetic Particle Imaging (MPI) Market Size by Country
        9.3.1 South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2029)
        9.3.2 Brazil Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        9.3.3 Argentina Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Market Size by Country
        10.3.1 Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2029)
        10.3.2 Turkey Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)
        10.3.4 UAE Preclinical Magnetic Particle Imaging (MPI) Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Preclinical Magnetic Particle Imaging (MPI) Market Drivers
    11.2 Preclinical Magnetic Particle Imaging (MPI) Market Restraints
    11.3 Preclinical Magnetic Particle Imaging (MPI) Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Preclinical Magnetic Particle Imaging (MPI) Industry Chain
    12.2 Preclinical Magnetic Particle Imaging (MPI) Upstream Analysis
    12.3 Preclinical Magnetic Particle Imaging (MPI) Midstream Analysis
    12.4 Preclinical Magnetic Particle Imaging (MPI) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Medicilon Company Information, Head Office, and Major Competitors
    Table 6. Medicilon Major Business
    Table 7. Medicilon Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
    Table 8. Medicilon Preclinical Magnetic Particle Imaging (MPI) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Medicilon Recent Developments and Future Plans
    Table 10. Bruker Corporation Company Information, Head Office, and Major Competitors
    Table 11. Bruker Corporation Major Business
    Table 12. Bruker Corporation Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
    Table 13. Bruker Corporation Preclinical Magnetic Particle Imaging (MPI) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Bruker Corporation Recent Developments and Future Plans
    Table 15. Mediso Company Information, Head Office, and Major Competitors
    Table 16. Mediso Major Business
    Table 17. Mediso Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
    Table 18. Mediso Preclinical Magnetic Particle Imaging (MPI) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Mediso Recent Developments and Future Plans
    Table 20. Magnetic Insight Company Information, Head Office, and Major Competitors
    Table 21. Magnetic Insight Major Business
    Table 22. Magnetic Insight Preclinical Magnetic Particle Imaging (MPI) Product and Solutions
    Table 23. Magnetic Insight Preclinical Magnetic Particle Imaging (MPI) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Magnetic Insight Recent Developments and Future Plans
    Table 25. Global Preclinical Magnetic Particle Imaging (MPI) Revenue (USD Million) by Players (2018-2023)
    Table 26. Global Preclinical Magnetic Particle Imaging (MPI) Revenue Share by Players (2018-2023)
    Table 27. Breakdown of Preclinical Magnetic Particle Imaging (MPI) by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 28. Market Position of Players in Preclinical Magnetic Particle Imaging (MPI), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 29. Head Office of Key Preclinical Magnetic Particle Imaging (MPI) Players
    Table 30. Preclinical Magnetic Particle Imaging (MPI) Market: Company Product Type Footprint
    Table 31. Preclinical Magnetic Particle Imaging (MPI) Market: Company Product Application Footprint
    Table 32. Preclinical Magnetic Particle Imaging (MPI) New Market Entrants and Barriers to Market Entry
    Table 33. Preclinical Magnetic Particle Imaging (MPI) Mergers, Acquisition, Agreements, and Collaborations
    Table 34. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value (USD Million) by Type (2018-2023)
    Table 35. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Share by Type (2018-2023)
    Table 36. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Forecast by Type (2024-2029)
    Table 37. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2023)
    Table 38. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Forecast by Application (2024-2029)
    Table 39. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2023) & (USD Million)
    Table 40. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2024-2029) & (USD Million)
    Table 41. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2023) & (USD Million)
    Table 42. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2024-2029) & (USD Million)
    Table 43. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 44. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 45. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2023) & (USD Million)
    Table 46. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2024-2029) & (USD Million)
    Table 47. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2023) & (USD Million)
    Table 48. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2024-2029) & (USD Million)
    Table 49. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 50. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 51. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2023) & (USD Million)
    Table 52. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2024-2029) & (USD Million)
    Table 53. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2023) & (USD Million)
    Table 54. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2024-2029) & (USD Million)
    Table 55. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Region (2018-2023) & (USD Million)
    Table 56. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Region (2024-2029) & (USD Million)
    Table 57. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2023) & (USD Million)
    Table 58. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2024-2029) & (USD Million)
    Table 59. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2023) & (USD Million)
    Table 60. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2024-2029) & (USD Million)
    Table 61. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 62. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 63. Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2018-2023) & (USD Million)
    Table 64. Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type (2024-2029) & (USD Million)
    Table 65. Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2018-2023) & (USD Million)
    Table 66. Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Application (2024-2029) & (USD Million)
    Table 67. Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 68. Middle East & Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 69. Preclinical Magnetic Particle Imaging (MPI) Raw Material
    Table 70. Key Suppliers of Preclinical Magnetic Particle Imaging (MPI) Raw Materials
List of Figures
    Figure 1. Preclinical Magnetic Particle Imaging (MPI) Picture
    Figure 2. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type in 2022
    Figure 4. Structural Imaging
    Figure 5. Functional Imaging
    Figure 6. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application in 2022
    Figure 8. Pharmaceutical Companies Picture
    Figure 9. Contract Research Organization (CRO’s) Picture
    Figure 10. Biotech Companies Picture
    Figure 11. Others Picture
    Figure 12. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Preclinical Magnetic Particle Imaging (MPI) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Region in 2022
    Figure 17. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Preclinical Magnetic Particle Imaging (MPI) Revenue Share by Players in 2022
    Figure 23. Preclinical Magnetic Particle Imaging (MPI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Preclinical Magnetic Particle Imaging (MPI) Market Share in 2022
    Figure 25. Global Top 6 Players Preclinical Magnetic Particle Imaging (MPI) Market Share in 2022
    Figure 26. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Share by Type (2018-2023)
    Figure 27. Global Preclinical Magnetic Particle Imaging (MPI) Market Share Forecast by Type (2024-2029)
    Figure 28. Global Preclinical Magnetic Particle Imaging (MPI) Consumption Value Share by Application (2018-2023)
    Figure 29. Global Preclinical Magnetic Particle Imaging (MPI) Market Share Forecast by Application (2024-2029)
    Figure 30. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Preclinical Magnetic Particle Imaging (MPI) Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Preclinical Magnetic Particle Imaging (MPI) Consumption Value (2018-2029) & (USD Million)
    Figure 64. Preclinical Magnetic Particle Imaging (MPI) Market Drivers
    Figure 65. Preclinical Magnetic Particle Imaging (MPI) Market Restraints
    Figure 66. Preclinical Magnetic Particle Imaging (MPI) Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Preclinical Magnetic Particle Imaging (MPI) in 2022
    Figure 69. Manufacturing Process Analysis of Preclinical Magnetic Particle Imaging (MPI)
    Figure 70. Preclinical Magnetic Particle Imaging (MPI) Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Medicilon
Bruker Corporation
Mediso
Magnetic Insight

Related Reports

Global Preclinical Magnetic Particle Imaging (MPI) Supply, Demand and Key Producers, 2023-2029

Global Preclinical Magnetic Particle Imaging (MPI) Supply, Demand and Key Producers, 2023-2029

date 02 Mar 2023

date Medical Devices & Consumables

The global Preclinical Magnetic Particle Imaging (MPI) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Preclinical Magnetic Particle Imaging (MPI) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Preclinical Magnetic Particle Imaging (MPI) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Preclinical Magnetic Particle Imaging (MPI) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Preclinical Magnetic Particle Imaging (MPI) Supply, Demand and Key Producers, 2024-2030

Global Preclinical Magnetic Particle Imaging (MPI) Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Devices & Consumables

The global Preclinical Magnetic Particle Imaging (MPI) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

preclinical magnetic particle imaging mpi

Preclinical Magnetic Particle Imaging (MPI)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>